-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Orchard Therapeutics plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q3 2023.
- Orchard Therapeutics plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 228B shares, a 78.2% increase year-over-year.
- Orchard Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 128M shares, a 3.24% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)